Explore the explosive growth of immuno-oncology in Head and Neck Squamous Cell Carcinoma from 2012-2022, tracing scientific breakthroughs that redefined treatment approaches.
Explore the revolutionary advances in immunomodulation therapy for head and neck squamous cell carcinoma, including checkpoint inhibitors, bispecific antibodies, and cell therapies.
Exploring the complex relationship between regulatory T cells and cancer stem cells in head and neck squamous cell carcinoma and its therapeutic implications.